Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IDEXX LABORATORIES INC /DE Director's Dealing 2015

Feb 9, 2015

30016_dirs_2015-02-09_14a86216-52ac-494e-91a2-cba86118e034.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2015-02-05

Reporting Person: HENDERSON REBECCA M (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-02-05 Common Stock M 2934 $56.95 Acquired 10282 Direct
2015-02-05 Common Stock S 2934 $156.2719 Disposed 7348 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2015-02-05 Non-Qualified Stock Option (right to buy) $56.95 M 2934 Disposed 2015-02-13 Common Stock (2934) Direct

Footnotes

F1: The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $155.8950 to $156.7233, inclusive. The reporting person hereby undertakes to provide upon request to SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.

F2: Grant of options to buy shares of common stock that vested on 02/14/2009.